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Due to their relative easy synthesis and commercial availability, nanovectors based
on dendrimers and dendrons are among the most utilized non-viral vectors for gene
transfer. Concomitantly, recent advances in molecular simulations and computer archi-
tectures not only allow for accurate predictions of many structural, energetical, and even-
tual self-assembly features of these nanocarriers per se, but are able to yield fundamental
information about the interactions of these nanovectors with their nucleic acid cargoes at
a molecular level. In this work, we aim at reviewing some of our own efforts in the field
of multiscale molecular modeling of these fascinating materials. This review is written
by computational scientists for experimental scientists, with the specific purpose of illus-
trating the potentiality of these methodologies and the usefulness of multiscale molecular
modeling as an innovative and complementary tool in their current research.
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Nanotechnology and drug delivery
The predominant methods to deliver drugs are
oral and injection, which has limited the progress of
drug development. Most drugs have been formu-
lated to accommodate per os or intramuscular/intra-
venous delivery routes, which are not always the
most efficient means for a particular therapy. New
biologic drugs such as proteins and nucleic acids
(NAs) require novel delivery technologies that will
minimize side effects and lead to better patient
compliance. Market forces are also driving the need
for new, effective drug delivery methods; mean-
while, patent expirations are driving pharmaceutical
companies to reformulate their products. Further-
more, drug candidates that did not pass through the
trials phases may be reformulates to be used with
new drug delivery systems.
Innovative drug delivery systems may make it
possible to use certain chemical entities or biologics
that were previously impractical because of their
toxicity or because they were impossible to admin-
ister. For example, drug targeting is enabling the
delivery of chemotherapeutical agents directly to
tumors, thereby drastically reducing systemic side
effects. The current research in the field is continu-
ally pursuing new ways to deliver macromolecules
that will facilitate the development of new biologi-
cal products such as bio-blood proteins and
bio-vaccines. Similarly, the success of DNA- and
RNA-based therapies will dramatically depend on
the availability of effective drug delivery tech-
niques.
In addition to the commonly used oral and in-
jection routes, drugs can also be administered
through other means, including transdermal, trans-
mucosal, ocular, pulmonary, and implantation. The
mechanisms used to achieve alternative drug deliv-
ery typically incorporate one or more of the follow-
ing materials: biologics, polymers, silicon-based
materials, carbon-based materials, or metals. The
substances are structured in microscale and, more
recently, nanoscale formats.
The United States National Nanotechnology
Initiative (NNI), launched in October 2000, has for-
mulated ten potential research and development tar-
gets to be reached by 2015. Five of these research
goals are relevant to drug development and deliv-
ery: i) no suffering and death from cancer when
treated, ii) advanced materials and manufacturing,
iii) pharmaceutical synthesis and delivery, iv) con-
verging technologies from the nanoscale, and v)
life-cycle biocompatible/sustainable development.
This emphasis exemplifies the importance of
nanotechnology in the progress of medicine.
D. MARSON et al., Genes within Bottles. Synergism Between Simulation …, Chem. Biochem. Eng. Q. 26 (4) 447–465 (2012) 447
*Corresponding author: phone: +39-040-5583750. fax: +39-040-569823.
E-mail: Sabrina.Pricl@di3.units.it
Original scientific paper
Received: May 4, 2012
Accepted: July 26, 2012
Generally speaking, the efficiency of drug de-
livery to various part of the body is directly affected
by particle size. Nanostructure-mediated drug de-
livery, a key technology for the realization of
nanomedicine, has the potential to enhance drug
bioavailability, improve the timed release of drug
molecules, and enable precision drug targeting.
Nanoscale drug delivery systems can be imple-
mented within pulmonary therapies, as gene deliv-
ery vectors, and in stabilization of molecules that
would otherwise degrade too rapidly. Additional
benefits of using targeted nanoscale drug carriers
are reduced drug toxicity and more efficient drug
distribution. Anatomic features such as the
blood-brain barrier, the branching pathway of the
lungs, and the tight epithelial junctions of the skin
make it difficult for drugs to reach the desired
pathological targets. Nanostructured drug carriers
may substantially help to penetrate or overcome
these hurdles to drug delivery. Advantages of
nanostructured-mediated drug delivery further in-
clude the ability to deliver drug molecules directly
into cells, and the capacity to target tumors within
healthy tissues:2h) in fact, nanoscale drug delivery
architectures are able to penetrate tumors due to the
discontinuous (or leaky) nature of the tumor
microvasculature, which typically contains pores
ranging from 100 to 1000 nm in diameter (see be-
low). The microvasculature of healthy tissues varies
by tissue type, but in most tissues including the
heart, brain, and lung, there are tight intercellular
junctions less than 10 nm wide. Therefore, tumor
within these tissue types can be selectively targeted
by creating drug delivery nanostructures greater
than the intercellular gap of the healthy tissue but
smaller that the pores found within the tumor
vasculature.
Equally important, through the precise control
of the drug carrier architecture, the release profile
of the drug can be tuned to achieve a desired kinetic
profile. As a common notion, the ideal release pro-
file for most conventional drugs would follow a
steady release rate so that the drug levels in the
body remains constant while the drug is being ad-
ministered.
So far, various nanoscale architectures can be
realized to achieve efficient drug transport and near
zero-order release kinetics, and these include solid
and hollow nanospheres, nanotubes, and lin-
ear/branched/hyperbranched macromolecules. To
generate the required nanostructures, different fab-
rication methods can be used depending on the spe-
cific type and nature of the materials, comprising
molecular self-assembly, bio-aggregation,
nanomanipulation, photochemical patterning, mo-
lecular imprinting, layer-by-layer electrostatic or
vapor deposition.
Gene delivery: a primer
With the conclusion of the human genome-se-
quencing project, the medical research community
has an unparalleled opportunity to understand and
cure diseases on a genetic level. Specifically, gene
therapy aims at delivering DNA, RNA, or antisense
sequences that alter gene expression within a spe-
cific cell population, thereby manipulating cellular
processes and responses. A naked DNA/RNA in-
jection into local tissues or into the systemic circu-
lation is probably the simplest and safest approach
to gene therapy. However, due to the rapid degrada-
tion by nucleases and fast clearance by the mono-
nuclear phagocyte system, the gene expression/si-
lencing level and the area of tissue treated after a
bare nucleic acid injection are severely limited.
Consequently, the development of gene therapy
vectors with sufficient targeting ability, transfection
efficiency, and safety must be achieved before gene
therapy can be routinely used in man. Perhaps,
foremost among these is the issue of delivery. The
in vivo use of DNA/small-interfering RNA (siRNA)
effective against cancer or other genetic diseases re-
lies on the availability of a delivery vehicle that can
be systematically administered to reach the target
cells. Moreover, because sufficient intact, func-
tional genetic material must be delivered into cells
to reach an effective intracellular concentration, and
to limit potential side effects due to a randomized,
general transfection of normal, non-target tissues, it
is also crucial to develop means of directing such a
delivery vehicle specifically to the target cells.5
Synthetic nanoscale drug delivery systems, or
nanovectors, offer exciting perspectives in this re-
spect. They can be structurally varied, are relatively
safe to produce, and are able to carry large and di-
verse genetic material into cells. Accordingly,
studying their biological and physic-chemical prop-
erties by structural modification represents an excit-
ing challenge for chemists as this approach con-
stantly provides new and valuable information for
the design of more complex and efficient sys-
tems.2c), 2f), However, any synthetic agent to deliver
genetic material specifically will be exposed to bio-
logical mechanisms that unavoidably limit its traf-
ficking both outside and inside the cells, as exem-
plified in Figure 1.
In summary, an ideal nanovector should tightly
compact the foreign nucleic acid, transport it
through cellular membranes while ensuring its pro-
tection from degradation and allow its recognition
and activation by the cell machinery. Of course, the
synthesis of a magic bullet affording all these skills
together remains idealistic; nevertheless, many syn-
thetic vectors have been active enough to justify
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concentrated research efforts and sometimes, even
commercialization.
Dendritic nanovectors for gene therapy
Dendrimers and dendrons are classes of macro-
molecules with highly branched three-dimensional
architectures whose structural elements can be
tuned to affect both surface and internal properties
of the macromolecules themselves. Dendrimer
structures can be divided into three main compo-
nents: a core, an interior, and a shell (see Figure
2a). The core affects the overall 3D shape of the
molecule (spherical, ellipsoidal, cylindrical, etc.),
the interior influences the eventual capacity of the
macromolecule to host small-molecule guests and,
finally, the outer shell can be functionalized to
maximize the interactions with a cargo agent and/or
with, e.g., a given receptor on the cell surface. The
number of branch points increases upon moving
from the dendrimer core to its surface and defines
the so-called dendrimer generation (G). Dendrons
(Figure 2b) are wedge-shaped dendrimer sections
with multiple terminal groups and a single reactive
function at the focal point. In addition to the
dendrimer features described above, dendrons offer
the extra-option of orthogonal reactions utilizing
the distinct focal point.
Given their peculiar molecular architectures,
dendrimeric nanovehicles are an attractive platform
for drug delivery, in light of the presence of a cen-
tral cavity and channels between their branches
wherein drugs can be entrapped. In addition to drug
loading within this void spaces, drug can be bound
or grafted onto tailorable functional groups, as is
the case of nucleic acid delivery. This affords
the possibility of incorporating not only multiple
and different drug molecules within the same
dendrimer/dendron, but also multiple targeting lig-
ands as well.
In aqueous conditions, dendrimer conforma-
tions are affected by ionic strength and pH, with
changes depending on the type of charged groups
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F i g . 1 – Hurdles in gene delivery following in vivo adminis-
tration. The (nano)vector system should be soluble and inject-
able, avoid adhesion (i.e., non-specific binding) to tissues,
aggregation, embolization, and phagocytosis, extravasate, find
a way to the inside of the target cells, escape from the
endosomal/lisosomal degradation and, in some cases, be trans-
ported into the nucleus. Reprinted with permission from
Nishikawa, M.; Takakura, Y.; Hashida, M. Theoretical consid-
erations involving the pharmacokinetics of plasmid DNA. Adv.
Drug Delivery Rev., 2005, 57, 675–688. Copyright {2005}
Elsevier B.V.
F i g . 2 – (a) Model structure of a generation 2 (G2)
dendrimer featuring ammonia as the core and amidoamine as
the repeating (branching) units. The ammonia core nitrogen
atom is in a sandy brown color, the dendrimer interior
(branches) are painted in sienna, while the terminal –NH2
groups constituting the outer shell are colored in sea green. (b)
Model structure of a G2 dendron featuring ammonia as the
core and amidoamine as the repeating (branching) units. The
ammonia core nitrogen atom is in a sandy brown color, the
dendrimer interior (branches) are painted in sienna, while the
terminal –NH2 groups constituting the outer shell are colored
in sea green. The focal point atom amenable to further
derivatization is highlighted in dark red.
eventually present at the dendrimer surface. The
dendrimers most widely used so far in clinical ap-
plications are the poly(amidoamine) or PAMAM
dendrimers, consisting of alkyl-diamine core and
tertiary amine branches. The amino surface consists
of polar, highly reactive primary amine groups
(Figure 2). The surfaces of the amino-functional
PAMAM dendrimers are thus cationic and can be
derivatized, either through ionic interactions with
negatively charged molecules, or using many
well-known reagents for covalent functionalization
of primary amines. Importantly, at physiological pH
(7.4) the primary amines are protonated in PAMAM
dendrimers; this condition allows for efficient com-
plex formation between the cationic dendritic
nanovector and anionic DNA/RNA (the resulting
supermolecular assembly often called dendriplex)
mainly via electrostatic interactions.
When employed as nanovectors, dendrimers
and dendrons are injected at the systemic level
(intravascularly) to execute specific diagnostic
and/or therapeutic missions at the biological target
site. This could be a tumor mass, an inflamed por-
tion of the vasculature, or any district within the hu-
man body where abnormal cells are proliferating.
Before reaching the target site, the blood-born den-
dritic nanovector must make its way into the circu-
latory system passing a multitude of barriers that
simply tend to sequester, digest and/or expel any
foreign object. Additional impediments are of the
biological barrier type, which include the reticular
endothelial system (RES), constituted by phagocytes,
specialized cells lining the liver, spleen, bone mar-
row, and lymphatic tissues, which recognize exter-
nal molecules and remove them from the circula-
tion. Moreover, it is important to note that the type
and severity of the barrier is disease and patient
specific.
However, success in targeting is not just about
performance at the target site. There will be for in-
stance loss of drug from the carrier by anticipated
release or degradation, loss of the cargo/carrier
complex through uptake into non-target sites, or re-
duced thermodynamic activity of the active princi-
ple once it is sequestered by proteins. The system
may fail to reach the target in sufficient quantity,
and payload release rate and the rate of diffusion of
the free drug may be suboptimal to achieve thera-
peutic effects. It is one thing for a nanocarrier to
reach a target tissue but another for its active cargo
to be still bound to its vector and not lost en route
or, conversely, bound too tightly that it is not re-
leased at the site of action. Recirculation of systems
clearly provides further opportunity to engage with
the target, but also prolongs the lifetime of the
carrier in the circulation and, with most systems
presently available, this increases the chances of
drug leakage and premature drug loss if release is
time-dependent, rather than triggered by some
mechanism (e.g., pH variation or enzymatic reac-
tion) close to the target. Last but certainly not least,
the nanovector must be devoid of any (unwanted)
pharmacological action per se, and exert a mini-
mum (and, if possible, null) toxic effect on both tar-
get and off-target cells.
With such a complex biological scenario, and
with the multitude of possibilities chemists have at
hand, devising new, efficient and safe nanovectors
based only on empirical or semi-rational design has
become a tantalizing task. Thus, accurate predictive
mathematical or molecular models are fundamental
in identifying those properties that can maximize all
the structural and physico-chemical properties re-
quired to an ideal nanocarrier.
Multiscale molecular modeling
for (bio)nanotechnology
In recent years, the use of computer simula-
tions as a tool for bridging between microscopic
length and time scales and the macroscopic world
of the laboratory has been increasing exponentially.
The main reasons for this success is that, by using
computational chemistry and physics, a guess at the
interactions between molecules can be provided,
and `exact’ predictions of bulk properties can be
obtained. The predictions are `exact’ in the sense
that they can be made as accurate as we like, sub-
ject to the limitations imposed by the available
computer budget. At the same time, the hidden de-
tail behind bulk measurements can be revealed.
Simulations act as a bridge in another sense: be-
tween theory and experiment. A theory can be
tested by conducting a simulation using the same
model. The model can be tested by comparing with
experimental results. Also, simulations can be car-
ried out on the computer that are difficult or impos-
sible in the laboratory (for example, working at ex-
tremes of temperature or pressure).
The actual computational modeling of biologi-
cal macromolecules, mainly based on molecular
dynamics (MD) simulations, commonly revolves
around structure representations in atomic or
near-atomic detail, with a classical description of
physical interactions. In a typical MD simulation,
the atomic trajectories of a system of N (e.g., 106)
particles are generated by numerical integration of
Newton’s equation of motion, for a specific inter-
atomic potential, with certain initial and boundary
conditions. Such models have been quite successful
in complementing experimental data with struc-
tural, dynamic, and energetic information, but in-
volve substantial computational resources for larger
systems, or when long time scales have to be con-
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sidered. In particular, structure-activity calculation
applications, the formation and interaction of supra-
molecular assemblies, and the prediction of kinetic
and transport phenomena will necessarily involve
extremely extensive computational resources when
using models at atomic details, if they are feasible
at all.
Thus, we are also in the need of developing
some computational strategy to link the atomic
length and time scales of MD to the macroscopic
length and time scales (nanometers to micrometers
and nanoseconds to microseconds): the so-called
mesoscale phase. Only by establishing this connec-
tion from nanoscale to mesoscale it is possible to
build first principles methods for describing the
properties of new materials and systems for bio-
medical and life science applications, of which
RNA/DNA delivery systems are prototypical exam-
ples.
This linking through the mesoscale in which
the microstructure can be described over a length
scale of tens to hundred nanometers is probably the
greatest challenge to develop reliable first princi-
ples method for practical material design applica-
tions. Scale integration in specific contexts in the
field of (bio)macromolecular modeling can be done
in different ways. Any recipe for passing informa-
tion from one scale to another (upper) scale is based
on the proper definition of many-scale modeling
which considers objects that are relevant at that par-
ticular scale, disregards all degrees of freedom of
smaller scales, and summarizes those degrees of
freedom by some representative parameters (see
Figure 3).
As mentioned above, mesoscopic simulations
are performed using a coarse-grained molecular
model: the particle in a mesoscopic simulation is re-
lated to a group of several atoms in the correspond-
ing atomistic simulation. Dissipative Particle Dy-
namics (DPD) is one of the best established
mesoscopic simulation techniques, according to
which a set of particles moves following Newton’s
equation of motion, and interacts dissipatively
through simplified force laws. In the DPD model,
individual atoms or molecules are not represented
directly by the particle, but they are coarse-grained
into beads (see Figure 4). These beads represent lo-
cal fluid packages able to move independently.
DPD thus offers an approach that can be used
for modeling physical phenomena occurring at
larger time and spatial scales than some other
coarse-grained methods as it utilizes a momen-
tum-conserving thermostat and soft repulsive inter-
actions between the beads representing clusters of
atoms/molecules.
Specifically, the multiscale modeling strategy
developed by our group is based on the systematic
elimination of computationally expensive degrees
of freedom while retaining implicitly their influ-
ence on the remaining degrees freedom in the
mesoscopic model. At the coarse-grained (meso-
scopic) level, we employed the corresponding most
accurate and effective methods/simulation tech-
niques available to investigate physical properties
of each system at that level. Accordingly, using the
information obtained from atomistic MD simula-
tions we parameterized the coarse-grained (e.g.,
DPD) models that incorporate all essential phys-
ics/phenomena observed at the finer level. The gen-
eral strategy of our multiscale modeling approach
can be outlined as follows:6,
1) extensive explicit solvent atomistic MD cal-
culations on model compounds and their assembly
are carried out. These simulations provide us with
dynamic properties/energies that help us to identify
important interactions/correlations among the nano-
carriers and their cargoes which are to be used per se
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F i g . 3 – The multiscale molecular modeling concept: the
information obtained from simulations at a given (lower) char-
acteristic length and time scales is used as an input for the next
(upper) scale simulations.
F i g . 4 – The coarse-graining concept. Atomistic (left) and
coarse-grained DPD (right) representation of a
modified dendron as an example.
and/or exploited to parameterize the next scale
(mesoscale) simulation models.
(2) Using conformational and structural prop-
erties obtained from MD simulations at point (1) we
parameterize the DPD model in which each nano-
carrier and nucleic acid segment are represented as
single force centers (beads) and solvent is treated
explicitly in the presence of ions and counterions.
Langevin dynamics are then conducted using the
DPD representation of the system. These simula-
tions are about orders of magnitude computationally
less expensive than fully atomistic simulations,
therefore allowing us to simulate more realistic sys-
tems and to significantly extend the accessible time
scales. Most importantly, these type of simulations
yield topical information of the morphology of the
systems under investigation in a length scale (L)
range of 1  L  1000 nm; contemporarily, the
time scale can be extended up to seconds, that is,
where most of the critical energetical and structural
phenomena involved in several aspects of the per-
formance of these systems take place.
(3) Eventually, the equilibrium configurations
of the mesoscopic systems obtained at point (3) can
be mapped back to the corresponding atomistic
models, and then MD simulations can be used again
to obtain more accurate structural/energetical infor-
mation of the corresponding supramolecular sys-
tems (e.g., the case of self-assembled nanovectors,
vide infra).
Under the multiscale molecular modeling per-
spective outlined above, the current ambitious aim
of our research group is to reach the domain of nu-
cleic acid delivery system engineering by building
from fundamental principles of physics and chemis-
try. Hence, for fundamental predictions to play a di-
rect role in these materials innovation and design, it
is mandatory to bridge the micro-macro gap, thus
establishing a tight and direct coupling between in
silico and in vitro/in vivo experiments.
The importance of nanodimensions
Dendrimers (or any other macromolecule) en-
tering the systemic circulation distribute to tissues
largely via the bloodstream. Therefore, the blood
flow rate determines the delivery rate of macro-
molecules to each tissue. Dendrimers in the circula-
tion have direct access to the capillary endothelial
cells, as well as various circulating cells in the
blood. These cells have the opportunity to take up
the macromolecules via specific or non-specific in-
teractions. The interaction of macromolecules with
parenchymal cells in tissues can occur only when
they have access through the endothelial lining. The
structure of the blood capillary walls varies greatly
depending on the organ. In addition, pathological
states such as inflammation could change the struc-
ture. On the basis of the morphology and continuity
of the endothelial layer and the basement mem-
brane, the capillary endothelium can be divided into
continuous, fenestrated, and discontinuous endothe-
lium.
Tight junctions between endothelial cells and
underlying uninterrupted basement membrane char-
acterize the continuous endothelium, through which
the passage of polymeric molecules is greatly ham-
pered (see Figure 5, situation 1). Such type of endo-
thelium characterizes the skeletal, cardiac, and
smooth muscles, and can be found in lung, skin,
and subcutaneous tissues. Dendrimeric and other
polymer-based nanoparticles with diameters equal
or greater than 6 nm hardly interact with parenchymal
cells in these tissues, simply because of the barriers
posed by the endothelium. Endothelial cells having
fenestrae featuring a diaphragm – an opening 40–80 nm
in diameter – form the fenestrated endothelium
found in the intestinal mucosa, the endocrine and
exocrine glands, and the gromerulus and peritubules
of the kidney (see Figure 5, situation 2). However,
the passage of macromolecules through this type of
endothelium is limited by the presence of the base-
ment membrane. The discontinuous (or sinusoidal)
endothelium is found only in the liver, spleen, and
bone marrow. These capillaries are characterized by
endothelial gaps, intracellular junctions with a di-
ameter up to 30–500 nm and with either no base-
ment membrane (liver) or a discontinuous basement
membrane (spleen and bone marrow). Therefore,
parenchymal cells in these tissues can be accessed
by macromolecules with relatively high molecular
weight and, consequently, large dimensions (see
Figure 5, situation 3). A similar situation (i.e., big
fenestrations and enhanced vascular permeability of
nanoparticle-based drug delivery systems) are also
found in several solid tumors.
452 D. MARSON et al., Genes within Bottles. Synergism Between Simulation …, Chem. Biochem. Eng. Q. 26 (4) 447–465 (2012)
F i g . 5 – The concept of nanoparticle extravasation from
different endothelial junctions/fenestrations
According to the above discussion the size and,
hence, the structure of dendrimers as a function of
pH is a critical issue for their utilization as drug
delivery vehicles in physiological environments (pH
= 7.4). Molecular simulations can provide insights
into the structure and the properties of dendrimers as
a function of generation by yielding, for instance, the
values of the radius of gyration Rg and the corre-
sponding radial distribution functions of the
dendrimers via fully atomistic MD simulations in ex-
plicit solvent, counterions, and ionic strength.
The radius of gyration Rg is related to the
square root of the second invariant of the first order
tensor S, and takes into account the spatial distribu-
tion of the atom chain by mediating over all N mo-
lecular components. For a dendrimer, the mean-square
radius of gyration is defined by:











where R is the center of mass of the dendrimer, ri
and mi are the position and mass of the ith atom,
and Mw refers to the total mass of the dendrimer.
The Rg values estimated by MD simulations for
ethylenediamino (EDA)-core PAMAM dendrimers
of generation 1 to 6 (G1-G6) are shown in Figure 6
as a function of the dendrimer Mw and listed in the
third column of Table 1 as a function of the
dendrimer generation G. As can be seen from these
data, the dimensions of these nanocarriers increase
linearly with Mw; also, their overall dimensions are
such that, according to the above discussion, their
extravasation can easily take place through the
fenestrated endothelium and even through the endo-
thelial cells tight junctions. Importantly, these val-
ues are in excellent agreement with those previ-
ously determined by SAXS experiments, and with
other MD simulations, as evidenced in Table 1.
It is interesting at this point to recall that the in-
ternalization and accumulation of PAMAM-NH2
dendrimers in the cellular endosomes result in the
acidification of the overall environment. As a con-
sequence, protonation of the dendrimers tertiary
amine nitrogens takes place as a buffering mecha-
nism, which triggers the diffusion and accumulation
of Cl– counterions into the endosomes. These, in
turn, results in an increased endosomal osmotic
pressure and eventually rupture of the endosomal
membrane and release of its contents, including the
loaded dendrimers, into the cytoplasm of the tar-
geted cells. As shown in Figure 1 and Table 1, and
as expected, the dimensions of the PAMAMs in-
crease with increasing generation and, coherently,
the Rg values at lower pH (e.g., pH = 5) are greater
than the corresponding values at pH = 7.4 by virtue
of the protonation of the tertiary amine nitrogen at-
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F i g . 6 – Log-log plot of Rg calculated from MD simulations
as a function of the PAMAM molecular weight. Green symbols,
pH = 7.4; red symbols, pH = 5. From PAMAM dendrimers for
siRNA delivery: computational and experimental insights, Pa-
van, G.M.; Posocco, P.; Tagliabue, A.; Maly, M.; Malek, A.;
Danani, A.; Ragg, E.; Catapano, C.V.; Pricl, S. Chemistry Eur.
J. 16(26), Copyright © [2010], John Wiley & Sons,
http://onlinelibrary.wiley.com/doi/10.1002/chem.200903258/pdf.
T a b l e 1 – Radius of gyration Rg values (Å) for PAMAM dendrimers obtained from MD simulations at two different pH values
(standard deviation in parenthesis). For comparison, experimental values obtained through SAXS experiments and theoretical values
derived from previous MD simulations are given. From PAMAM dendrimers for siRNA delivery: computational and experimental in-
sights, Pavan, G.M.; Posocco, P.; Tagliabue, A.; Maly, M.; Malek, A.; Danani, A.; Ragg, E.; Catapano, C.V.; Pricl, S. Chemistry Eur.
J. 16(26), Copyright © [2010], John Wiley & Sons, http://onlinelibrary.wiley.com/doi/10.1002/chem.200903258/pdf.
Generation pH = 5 pH = 7.4 SAXS15 Other MD simulations16
G1 10.19 (0.34) 9.85 (0.30)
G2 13.88 (0.37) 14.44 (0.41)
G3 17.96 (0.17) 16.25 (0.38) 15.8[a] 16.5[b] 15.09[b]
G4 21.00 (0.22) 19.00 (0.21) 17.1 17.6 18.6 16.78[c]
G5 24.23 (0.18) 22.43 (0.29) 24.1 25.3 23.07 20.67
G6 28.90 (010) 27.21 (0.11) 26.3 27.5 27.5 26.76
[a]In CH3OH from sphere model.. [b]In CH3OH from Guinier plot.. [c]In explicit water and counterions.
oms which, in turn, leads to a molecular expansion
by internal charge repulsion. This allows for an en-
hanced water and counterions penetration into the
dendrimer branches, with the ultimate consequence
of nanovector swelling. This behavior is commonly
known as the proton sponge effect, as the influx of
water and chlorine counterions to compensate the
increased protonation state of the dendrimer makes
the nanocarriers behave like a virtual proton
sponge.
Another substantial effect of the degree of
protonation of cationic dendrimers (such as
PAMAMs) for nucleic acid delivery is that, by low-
ering the pH and, hence, increasing the dendrimer
protonation level, more counterions are expected to
move inside the dendrimer, resulting in an ultimate
greater dendrimer swelling. Figures 7a and 7b plot
the radial density distributions of all PAMAM gen-
erations at low and neutral pH, respectively. It can
be inferred that, in presence of solvent and both at
neutral or low pH, for G1-G6 the density distribu-
tion is characterized by a maximum at small R val-
ues, and then decreases somewhat monotonically
with increasing R. This effect becomes more evi-
dent as the pH decreases, and constitutes an indica-
tion that the dendrimer core region is denser than
the outer part. Because of this hollowness at the
middle regions of the molecule, a significant num-
ber of water molecules are allowed to penetrate
within the dendrimer inner branches.
A further, peculiar feature of dendrimeric struc-
tures which may affect their performance as
nanocarriers is the high degree of back-folding. The
usual schematic diagrams found in the literature for
dendrimers, particularly the 2D representations,
convey the idea that the terminal groups are located
at the periphery of the molecule. However, the ac-
tual MD simulations reveal the presence of a sub-
stantial back-folding of the end groups toward the
dendrimer core. To quantify this aspect, the radial
distribution functions for terminal nitrogens for var-
ious generations are reported in Figures 7c and 7d.
This indicates that the end groups are sufficiently
flexible to interpenetrate nearly the whole mole-
cule. In particular, the end groups of higher genera-
tions come even close to the core of the molecule,
and the extent of back-folding increases with the in-
crease of generation. This effect is again more evi-
dent at neutral pH; higher generations show evident
peaks near the core of the molecule and, for smaller
generations, the back-folding pervades the entire
molecular architecture. Obviously, the presence of a
substantial backfolding is detrimental to NA bind-
ing, as less protonated terminal groups are available
on the dendrimer surface; accordingly, the overall
dendrimer surface charge is diminished, the corre-
sponding ionic interactions with the NA is lower,
and the NA cargo might be lost along the way to the
target cell under the action of drag forces in the
blood stream or the uptake of plasma proteins. On
the other hand, a too strong interaction between the
nanovector and its cargo can turn out to be unfavor-
able in a later stage of the delivery process, that is
during NA release in the cell cytoplasm: a tight
electrostatic bond between the two molecular enti-
ties may disfavor the NA detachment from its vec-
tor, thus making the NA unavailable for further,
therapeutic action.
But how about dimensions when the dendri-
meric nanovector and its nucleic acid cargo com-
plex and form a dendriplex? Once again, to try to
find an answer to this crucial question we can resort
to computer-assisted simulations and characterize
the conformational change of dendrimer and the nu-
cleic acid upon binding by calculating the values of
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F i g . 7 – Radial density distributions for PAMAM genera-
tions G1 to G6 (continuous lines) and water (broken lines) at
pH = 5 (a) and pH = 7.4 (b). Radial density distributions for
terminal nitrogens of PAMAM generations G1 to G6 at pH = 5
(c) and pH = 7.4 (d). Color legend: red, G1; light green, G2;
dark green, G3; blue, G4; purple, G5; dark red, G6. From
PAMAM dendrimers for siRNA delivery: computational and ex-
perimental insights, Pavan, G.M.; Posocco, P.; Tagliabue, A.;
Maly, M.; Malek, A.; Danani, A.; Ragg, E.; Catapano, C.V.;
Pricl, S. Chemistry Eur. J. 16(26), Copyright © [2010], John
Wiley & Sons,
http://onlinelibrary.wiley.com/doi/10.1002/chem.200903258/pdf.
the radius of gyration of the entire complex, Rg
compl,
and those of the dendrimer and the NA within the
complex, Rg
dend and Rg
NA, respectively. As an exam-
ple, Table 2 shows the relevant values again for
PAMAM dendrimers in complex with a RNA frag-
ment of 21 base-pairs. At both pH values and for
each dendrimer generation, Rg
NA is significantly
smaller than Rg
dend, testifying the tendency of the
NA fragment to partially penetrate inside the
dendrimeric structure. Nevertheless, as expected,
the biggest part of the NA double helix still remains
outside the dendrimer, and this reflect in a Rg
compl
value being larger than Rg
dend. Furthermore, the NA
is a duplex many therapeutic NAs are in a duplex
form, and the base pairing/stacking interactions be-
tween the opposite strands concur to confer an in-
trinsic rigidity to the overall structure, preventing a
substantial wrapping of the nucleic acid around the
dendrimer surface (see Figure 8).
Comparing Figure 9a and 9b, it can be seen
that, due to the swelling of the polymer, consider-
able water can penetrate inside the dendrimer. The
water uptake seems to be dependent on dendrimer
generation; in particular, at neutral pH, water diffu-
sion within the dendrimer branches decreases as G
increases. In any case, water molecules are detected
even close to the dendrimer cores at both pHs.
Upon NA complexation, all PAMAM generations
do not appear to undergo major conformational
changes, maintaining the dense core configuration
observed for isolated dendrimers (see Figures 7a
and 7b). Finally, the NA density distributions are
found well inside the corresponding dendrimer den-
sity profiles, indicating that the nucleic acid can
easily penetrate into the outmost dendrimer
branches, some base pairs reaching deeper into the
nanovectors structure. In concluding this section, it
is important to remark that also the dendriplexes
formed by G1-G6 PAMAMs as nanocarriers and
small fragments of NA, as are the so-called
small-interference RNA (siRNA),4 still possess di-
mension fully compatible with easy extravasation
through all types of endothelium.
Nano dimensions, mega interactions
Indeed, the ability of a nanocarrier to generate
a stable complex with its nucleic acid payload is a
background postulate for its usefulness in gene de-
livery. This property can be experimentally ex-
plored and quantified through the use of many dis-
parate techniques, ranging from the standard
Ethidium Bromide (EthBr) displacement fluores-
cence spectroscopy assay to the more sophisticate
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T a b l e 2 – Radius of gyration values Rg
compl(Å) for G4-G6 PAMAM dendrimers in complex with a 21 base-pairs RNA fragment
(standard deviations in parenthesis). The values for the dendrimer and siRNA within the corresponding complexes, Rg
dend and Rg
NA,
are also given. Adapted from PAMAM dendrimers for siRNA delivery: computational and experimental insights, Pavan, G.M.;
Posocco, P.; Tagliabue, A.; Maly, M.; Malek, A.; Danani, A.; Ragg, E.; Catapano, C.V.; Pricl, S. Chemistry Eur. J. 16(26), Copyright
© [2010], John Wiley & Sons, http://onlinelibrary.wiley.com/doi/10.1002/chem.200903258/pdf.
Generation








G4 23.65 (0.15) 22.06 (0.15) 19.56 (0.39) 23.01 (0.21) 19.56 (0.24) 20.08 (0.36)
G5 25.83 (0.10) 24.76 (0.10) 18.79 (0.33) 24.81 (0.14) 23.47 (0.15) 20.41 (0.21)
G6 30.01 (0.14) 29.38 (0.08) 19.76 (0.35) 28.39 (0.07) 27.41 (0.08) 19.43 (0.33)
and quantitative isothermal titration calorimetry
(ITC) or differential scanning calorimetry (DSC).
Multiscale molecular simulations, however, not
only can yield the same information in a less expen-
sive way (both from time and money standpoint),
but may offer a reliable molecular rationale to ex-
plain the generation, structural, ionic strength, and
other chemico-physical properties and mechanisms
determining the dependence of the affinity of a
given dendrimer/dendron carrier to its nucleic acid
cargo. This can be easily understood looking at Ta-
ble 3, in which the free energy of binding (Gbind)
between PAMAMs from generation G4 to genera-
tion G6 and a short fragment of double-stranded
(ds) RNA is listed, together with its major compo-
nents (i.e., the enthalpic contribution Hbind, and
the entropic term –TSbind, see Supporting Informa-
tion for more details)). As it can be seen from this
table, the affinity for all three dendrimer genera-
tions for the NA is very high, and increases with in-
creasing G, as expected.
As expected for the interaction of two highly,
oppositely charged macroions, the electrostatic part
of the nonbonded mechanical energy components
of Gbind, Eele, affords the predominant contribu-
tion to binding for each dendrimer generation and
at both pH values. On the other hand, due the polar
character of both nanovectors and cargo, the
desolvation penalty paid by these molecules upon
binding (GPB) is also quite substantial. The corre-
sponding mean values of the van der Waals and hy-
drophobic overall interaction energies (EvdW + GNP,
see Table 3) amount approximately to 10% of the
overall electrostatic components (Eele + GPB),
thus confirming the substantial electrostatic nature
of the interactions in the dendriplexes.
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F i g . 9 – Radial density distributions for PAMAM genera-
tions G4 to G6 in complex with siRNA (continuous lines), wa-
ter (broken lines), and siRNA (dotted-broken line) at pH = 5
(A) and pH = 7.4 (B). Color legend: blue, G4; purple, G5;
dark red, G6. From PAMAM dendrimers for siRNA delivery:
computational and experimental insights, Pavan, G.M.;
Posocco, P.; Tagliabue, A.; Maly, M.; Malek, A.; Danani, A.;
Ragg, E.; Catapano, C.V.; Pricl, S. Chemistry Eur. J. 16(26),
Copyright © [2010], John Wiley & Sons,
http://onlinelibrary.wiley.com/doi/10.1002/chem.200903258/pdf.
F i g . 8 – Snapshots taken from MD simulations of PAMAM
generations G6 in complex with GL3 siRNA at different
protonation levels. Top: low pH (= 5) structure; bottom: neu-
tral pH (= 7.4) structure. Dendrimers are depicted in colored
sticks representation, with the terminal NH3+ groups high-
lighted as white sticks-and-balls. The siRNA is outlined as a
golden ribbon. Sodium and chlorine counterions are portrayed
as purple and green sphere, respectively. Water is omitted for
clarity. From PAMAM dendrimers for siRNA delivery: compu-
tational and experimental insights, Pavan, G.M.; Posocco, P.;
Tagliabue, A.; Maly, M.; Malek, A.; Danani, A.; Ragg, E.;
Catapano, C.V.; Pricl, S. Chemistry Eur. J. 16(26), Copyright
© [2010], John Wiley & Sons,
http://onlinelibrary.wiley.com/doi/10.1002/chem.200903258/pdf.
Interestingly, a least-squares linear regression
fit of the values of Hbind versus –TSbind listed in
Table 3 (correlation coefficient R2=0.98) demon-
strates the linear relationship between the enthalpies
and the entropies of RNA binding to the PAMAMs
(Figure 10a). As this plot indicates, the binding en-
tropy decreases when the binding enthalpy in-
creases. One explanation for this observation is that
as the dendrimer forms favorable interactions by
wrapping the small RNA fragment with some of its
outer branches, both the dendritic arms and the
nucleobases involved in these interactions lose de-
grees of freedom upon binding. Moreover, solvent
molecules and stabilizing counterions associated
with the hydration shell of the nanovector and those
residing in the binding pocket in the major groove
of the siRNA also become rearranged. Similarly, a
plot of Hbind vs. Gbind (shown in Figure 10b) is
also linear (R2=0.99), again characteristic of classi-
cal enthalpy/entropy compensation.
The role of solvation in gene binding
by nanovectors
Soft colloids and macromolecules with flexible
structures and void pervading their entire complex
molecular structure are necessarily hydrated not
only in their outer shell. Indeed, ions and water can
penetrate along the tortuous pathways of holes and
channels of the macromolecular entity, eventually
reaching down to the inner core. In harmony with
the foregoing discussion of the propensity of
dendrimers to swell in water (particularly at low
pH) and of the role of the conformational and
chemico-physical features of a given dendrimers in
the corresponding ability to adapt to an environ-
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T a b l e 3 – Free energy of binding and its component for the formation between PAMAM G4, G5, and G6 and a small fragment
(21 base-pairs) of RNA under two pH conditions of physiological interest as obtained from MM/PBSA calculations at
T = 300K. All values are in kcal/mol. Standard errors of the means are reported in parenthesis.
pH = 7.4 pH = 5.0
G4/RNA G5/RNA G6/RNA G4/RNA G5/RNA G6/RNA
EvdW –44.58 (5.93) –66.50 (9.70) –71.29 (9.18) –87.18 (9.49) –114.57 (13.18) –135.77 (15.22)
Eele –27186.60 (210.40) –51796.44 (364.56) –86827.58 (1493.61) –57630 (619.27) –100315.04 (678.29) –158934.28 (2382.03)
EMM –27231.18 (209.94) –51862.94 (364.32) –86898.88 (1500.45) –57717.68 (624.39) –100429.61 (689.07) –159070.05 (2398.29)
GNP –11.12 (0.57) –17.56 (1.39) –15.21 (1.78) –20.14 (1.97) –24.46 (1.94) –26.33 (1.91)
GPB 26870.38 (203.46) 51227.80 (354.70) 85901.50 (1480.93) 56985.10 (603.46) 99307.69 (682.91) 157252.06 (2292.85)
H –371.92 (13.71) –652.69 (13.85) –1012.59 (29.70) –752.72 (27.97) –1146.38 (35.81) –1844.32 (31.78)
–TS +64.78 (3.64) +101.64 (13.14) +228.79 (25.64) +154.47 (16.74) +284.42 (29.23) +577.06 (56.88)
Gbind –307.14 –551.05 –783.80 –598.25 –861.96 –1267.26
F i g . 1 0 – Relationship between the enthalpy and the en-
tropy of siRNA binding to G4–G6 PAMAM dendrimers at two
different pH: 7.5 (green symbols) and 5 (red symbols). A) Plot
of H versus –TS and B) plot of H versus Gbind. The two
solid lines through the data are the best fit lines (see Table 3).
From PAMAM dendrimers for siRNA delivery: computational
and experimental insights, Pavan, G.M.; Posocco, P.;
Tagliabue, A.; Maly, M.; Malek, A.; Danani, A.; Ragg, E.;
Catapano, C.V.; Pricl, S. Chemistry Eur. J. 16(26), Copyright
© [2010], John Wiley & Sons,
http://onlinelibrary.wiley.com/doi/10.1002/chem.200903258/pdf.
mental change, Figure 11 shows the swelling capac-
ity of a triethanolamine (TEA)-core PAMAM as ob-
tained from computer simulations: indeed, in this
case the presence of a large core in the dendrimeric
structure favors the penetration of a high amount of
water molecules within the dendrimer interior
(compared to the EDA-core PAMAMs, see previ-
ous paragraph), particularly at high generations and
low pH (both fundamental parameters for efficient
delivery); moreover, the number of intra-dendrimer
water molecules grows almost linearly with pH.
Upon binding of the dendrimer to the nucleic
acid, water plays even more determining roles.
First, it creates a bridge between the carrier and the
DNA/RNA, by maintaining an hydration layer and
ensuring the instauration of a hydrogen bond net-
work between the carrier and the nucleic acid, criti-
cal to their complex formation and stability. More
important, perhaps, is the role of overall
solubilization. Water and the solution navigating
salts must pervade the entire system to guarantee
uniform hydration and dispersion of the loaded
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F i g . 1 1 – (a) Radius of gyration Rg as a function of the solution pH for G4-G6 TEA-core PAMAMs in complex with a small frag-
ment of double-stranded RNA. (b) Number of water molecules in the G4-G6 TEA-core PAMAM dendrimer interiors as a function of
the solution pH. Symbol legend: circles, G4; squares, G5, triangles, G6. Error bars are smaller than symbols. Reproduced from
Poly(amidoamine)-based dendrimer/siRNA complexation studied by computer simulations: effects of pH and generation on dendrimer
structure and siRNA binding, Karatasos, K.; Posocco, P.; Laurini, E.; Pricl, S., Macromol Biosci., 12(2), Copyright © [2012], John
Wiley & Sons, http://onlinelibrary.wiley.com/doi/10.1002/mabi.201100276/abstract. (bottom, left) Mesoscale morphologies of the as-
sembled systems between TEA-core dendrimers G6 and DNA. The dendrimers are represented as dark gray and yellow sticks while
the DNA is shown as light gray sticks. Water is portrayed as a light gray field. (bottom, right) DNA chains and water molecules distri-
bution within the architectures of the TEA-core DNA/G6 nanoscopic assembly. In this case, water is represented as a colored density
field: according to the scale reported in the lower left corners of the panels, blue density values are black, while high density values
are white. Adapted with permission Liu, X.X.; Wu, J.; Yammine, M.; Zhou, J.; Posocco, P.; Viel, S.; Liu, C.; Ziarelli, F.; Fermeglia,
M.; Pricl, S.; Victorero, G.; Nguyen, C.; Erbacher, P.; Behr, J.P.; Peng, L. Structurally flexible triethanolamine core PAMAM
dendrimers are effective nanovectors for DNA transfection in vitro and in vivo to the mouse thymus. Bioconjug. Chem., 2011, 22(12),
2461–2473. Copyright {2011} American Chemical Society.
nanoparticles, avoiding their aggregation and col-
lapse. Mesoscale simulations offer the possibility to
predict and study this type of behavior; in fact, a
typical result of a mesoscale simulation is the mor-
phology and the structure of matter at nanoscale
level at the desired environmental conditions.14c)
Let us then consider the lower panels of Figure 11,
where the nanoscale morphology of a DNA/G6
complexes of TEA-core dendrimer is presented. As
it can be seen from this figure, the TEA dendrimers
are able to complex the DNA strands efficiently and
homogeneously, with the DNA chains well
enwrapped in the systems and the absence of DNA
bundles at the nanoscopic level. Further, the water
density maps at the mesoscopic level not only sup-
port the lower-scale (i.e., atomistic MD) results dis-
cussed above of a higher degree of hydration but
also confirm the uniform water molecule distribu-
tion within the nucleic acid/TEA-core PAMAM
dendrimer.
From a structure-activity relationship (SAR)
standpoint, the enhanced swelling capacities of the
TEA-core dendrimers at low pH values may result
in a higher buffering capacity which, in turn, can be
beneficial to endosomal escape of the nucleic acid
cargo via the proton sponge effect. At the cellular
level, in fact, inadequate cytosolic access is one
major challenge that must be overcome if nano-
vector/DNA(RNA) systems are to become effective
in vivo therapeutics. The increased swelling and,
possibly, the increased proton sponge effect of more
flexible and open structure dendrimers such as the
TEA-core PAMAMs undoubtedly concur to en-
hance the capacity of these nanovectors and their
cargoes to enter the endosome, adsorb protons,
swell and cause an influx of negative (e.g., Cl–)
counterions which, in turn, creates an osmotic ef-
fect ultimately leading to water uptake. This escala-
tion of events are purported to cause endosome
membrane destabilization and rupture, with subse-
quent release of the nanodelivery complex in the
cellular cytosol. Thus, should the proton sponge ef-
fect be the operative mechanism underlying
endosome escape of the nanovector and release of it
payload, then flexibility, softness, and confor-
mational freedom are all key molecular parameters
in a dendrimer-based nanocarrier.
Multivalency in gene delivery
Multivalent systems are widely found in na-
ture, and especially in biology: adhesion of viruses
or bacteria to cells’ surface, cell to cell adhesion,
and cell to polyvalent molecule interactions. A
good example of multivalency resides in the de-
fense process of the immune system involving
bacteria, antibodies, and macrophages. Antibodies
have the ability to recognize non-self entities, such
as bacteria, upon polyvalent binding with antigens,
or other proteins, located at their surface. It is note-
worthy that weak ligand-receptor interactions can
be made much stronger simply by the simultaneous
bonding of these ligands to these multiple recep-
tors.
High-affinity molecular recognition of bio-
molecular targets is of crucial importance in the de-
velopment of synthetic systems capable of interven-
ing in biological pathways; multivalent recognition
is a key principle in enhancing binding strength and
hence developing systems with potential biomedi-
cal applications. Experimental studies and mathe-
matical models have demonstrated that once the
first ligand in a multivalent array has bound to the
target, the binding of a second ligand is usually a
cooperative, entropically less disfavored process,
with a local concentration effect also enhancing
binding.
Dendrimers and dendrons are inherent
multivalent ligands that can present multiple recog-
nition elements from a central scaffold. The scaf-
fold plays a crucial role because it molds the final
architecture in term of shape, orientation of recog-
nition elements, flexibility, size and valency. When
the multiple surface groups are ligands, the den-
dritic scaffolding can be considered to act as a kind
of nanoscaffolding, organizing the ligand array. As
such, dendritic systems have been widely exploited
for their potential applications in multivalent bio-
logical recognition. ,
Self-assembly is an incredibly powerful con-
cept in modern molecular science. The ability of
carefully designed building blocks to spontaneously
assemble into complex nanostructures underpins
developments in a wide range of technologies, from
materials science to molecular biology. Self-assem-
bly is a supramolecular approach which relies on
complementary noncovalent interactions, such as
electrostatic and van der Waals forces, hydrogen
bonds, coordination interactions and solvophobic
effects. In self-assembled structures, these temporal
intermolecular forces connect to the molecular scale
building blocks in a reversible, controllable, and
specific way. Of particular value are the possibili-
ties offered by self-assembly to generate nanoscale
complexity with relatively little synthetic input.
Furthermore, the ability of self-assembled super-
structures to behave as more than the sum of their
individual parts, and exhibit completely new types
of behavior, is of special interest and appealing in
(bio)nanotechnology.
There are a number of different ways in which
dendrimers or dendrons can be assembled in solu-
tion; perhaps the most efficient approach is the one
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that gives rise to well-defined (i.e., monodisperse)
assemblies of dendritic building blocks. The
supermolecular structures generated using this ap-
proach are generally based on well-established, spe-
cific intermolecular interactions; consequently, each
assembly contains a defined number of dendritic
building blocks. Such supermolecular dendrimeric
structures have an equivalent degree of structural
definition to a traditional covalent dendrimer; how-
ever, they are held together by reversible,
nonbonded interactions. Given the relative simplic-
ity of using self-assembly as a noncovalent syn-
thetic tool, this approach is relatively cost-effective,
and its potential for genuine future applications is
therefore significantly enhanced.
Surface-active amphiphilic molecules are
well-known to assemble into discrete structures
such as micelles and vesicles in water solution.
Amphiphilic dendritic systems are not exception
to this rule, and a range of dendrimers with
surfactant-like assembly properties have been re-
ported. Indeed, when mixed with water, the apolar
and polar regions of these Janus-type molecules
will attempt to phase separate via self-assembly
into structures such as micelles. Importantly, only
in some cases does the aggregation process give
rise to true micellar structures: this occurs at molec-
ular concentrations C greater than the so-called crit-
ical micellar concentration (CMC), which is one of
the key parameter in self-assembly. When C > CMC,
aggregates with a variety of different, non-micellar
structures – often ill-defined – are formed. In other
words, CMC defines the thermodynamic stability of
the micelles. The latter is a very critical property in
drug-delivery applications of micelles because in-
travenous injection of micellar solutions are associ-
ated with extreme dilutions by circulating blood
(usually about 25-fold dilution at bolus injection or
a much higher dilution at infusion). If the concen-
tration of a micelle forming molecule in the circula-
tion drops below the CMC, the micelles may be
prematurely destroyed, resulting in the release of
their cargo into the bloodstream before it reaches its
target. This, in turn, will not only result in a poor
therapeutic regime but, perhaps more importantly,
could be dangerous because off-target and other un-
wanted side effects might (and likely will) origi-
nate. On the other hand, amphiphilic compound
concentration cannot be increased above some criti-
cal values that correspond to the onset of micellar
aggregation and precipitation, provoked by the
interpenetration of the hydrophilic micellar coro-
nas.
Under these perspective, our group recently
synthesized a series of dendrons with a variety of
lipophilic units at their focal points (see Figure 12)
and tested these molecules for DNA binding and
cell transfection capacities, revealing a set of stimu-
lating evidences: not only all modified dendrons
were able to tightly bind DNA and efficiently
transfect cells, but for the first time and with the aid
of multiscale molecular modeling a structure-activ-
ity relationship (SAR) could be formulated between
the DNA binding affinity and the overall surface
charge m of the micellar assemblies but, perhaps
more importantly, the SAR could be extended to
cellular gene delivery, as m plays a fundamental
role in controlling the extent of the endosomal es-
cape (vide infra).13a,
Thus, state-of-the-art multiscale simulation
techniques were employed to monitor the dendrons
self-assembly processes and to gain an insight into
the types of aggregates eventually formed. First of
all, the simulations revealed that all hydrophobi-
cally modified dendrons of generation 1 were able
to form spherical supermolecular structures (see
Figure 13) with diameters Dm in the range of 3 – 5
nm (see Table 4).
The spherical geometry of the self-assembled
supramolecular entities is a direct consequence of
the conical molecular shape of each dendron, fea-
turing a relative large cationic head and a compara-
tively small lipophilic part. In fact, assembly geom-
etries for amphiphilic molecules is dictated by the
proportions of their polar and apolar domains, aptly
described by the so-called packing parameter
P = vh/a0lc, in which vh is the volume of the densely
packed hydrophobic segment, a0 is the effective
cross-sectional area of the hydrophilic group, and lc
is the chain length of the hydrophobic moiety nor-
mal to the interface. Based on simple geometric
considerations of micellar core volume vs. surface
area, it is easy to show that P < 1/3 is characteristic
of spherical micelles, 1/3 < P < 1/2 characterizes
self-assembly of cylindrical shape, 1/2 < P < 1 cor-
responds to vesicles, flat lamellae are formed at
P = 1 and, lastly, inverted micelles are expected for
P > 1.
With these rules for P value calculations in
mind, let us consider a generic micelle with a core
radius Rc, and made up of Nagg molecules. By
simple geometrical principles, then, the volume
Vc of the micellar core can be obtained as
V N v Rc agg h c  4 3
3 , the surface area of the
core as A N a Rc agg c 0 4
 and, finally, the
value of the micellar core radius as R v ac h 3 0.
If the micellar core is densely packed with the hy-
drophobic moieties filling the entire space, then the
radius of the micelle core cannot exceed the fully
extended length of the hydrophobic portion. Intro-
ducing this constraint into the expression for Rc, we
then arrive at the above stated condition 0  P  1/3
if an amphiphile is to form a spherical micelle.
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F i g . 1 2 – Synthetic pathway of first generation dendron-based nanovectors with different hydrophobic groups at the focal point. Reprinted
with permission from Jones, S.P.; Gabrielson, N.P.; Wong, C.H.; Chow, H.F.; Pack, D.W.; Posocco, P.; Fermeglia, M.; Pricl, S.; Smith, D.K.
Hydrophobically modified dendrons: developing structure-activity relationships for DNA binding and gene transfection. Mol Pharm., 2011, 8(2),
416–429. Copyright {2012} American Chemical Society.
F i g . 1 3 – Mesoscale modeling of amphiphilic dendrons showing aggregation into spherical micellar objects. (Left) Chol-G1-SP;
(middle) C12-G1-SP; (right) D2Gly-G1-SP. In all pictures, the yellow sticks represent the dendron head groups while colored spheres
are adopted to portray the various hydrophobic regions. The gray field is finally used to represent water. Reprinted with permission
from Jones, S.P.; Gabrielson, N.P.; Wong, C.H.; Chow, H.F.; Pack, D.W.; Posocco, P.; Fermeglia, M.; Pricl, S.; Smith, D.K.
Hydrophobically modified dendrons: developing structure-activity relationships for DNA binding and gene transfection. Mol Pharm.,
2011, 8(2), 416–429. Copyright {2012} American Chemical Society.
By coupling basic molecular modeling con-
cepts to the dimensional micellar parameters esti-
mated by mesoscopic simulations and listed in the
first three columns of Table 4, we were able to cal-
culate the corresponding value of packing parame-
ter P for all modified dendrons under hydrated con-
ditions. A cursory glance at the P values in Table 4
reveals that in all cases these numbers fall between
0.24 and 0.32, in agreement with the corresponding
spherical morphologies predicted by our meso-
scopic simulations.
The mesoscale simulations of these dendron
micelles carried out in the presence of DNA neatly
show that, in all cases, the overall systems consist
of parts of free, unfolded, single-chain DNA that
connect micelles on which a partial amount of DNA
has been adsorbed (see Figure 14). In other words,
all dendron/DNA complexes present a typical
beads-on-a-string structure, made of dendron mi-
celles connected by a DNA thread. Importantly, this
predicted morphology is supported by detailed
AFM studies between G4 PAMAM dendrimers
and DNA – indicative that these self-assemblies
of dendrons can be considered to be somewhat
like covalently bound higher generation spherical
dendrimers. These structures are also somewhat
reminiscent of the structure of open chromatin,
which consists of an array of nucleosome core par-
ticles, separated from each other by up to 80 base
pairs of linker DNA. However, in clear contrast
to the periodic structure of open chromatin, the
dendron micelles appear to be distributed in a
non-periodic, more irregular way.
Summarizing the overall evidence stemming
from the analysis of data in Table 4, as obtaiend
from the application of the multiscale molecular
modeling recipe, led to the following, important
considerations:
– the overall series of spermine-based
amphiphilic dendrons assemble into small, spheri-
cal micelles in water and in the presence of physio-
logical ionic strength conditions (150 mM), as ex-
perimentally verified for similar systems.
– the different architectures of the hydrophobic
portion resulted in differently sized micelles and/or
a different number of dendrons per micelle Nagg,
and, hence, a different micellar surface charge den-
sity m.
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T a b l e 4 – Values of the micellar diameter Dm (nm), core
radius Rc (nm), aggregation number Nagg, packing parameter P,
and micelle surface charge density m (e/nm
2) for the different
modified dendrons (Figure 16) as obtained from mesoscale
simulations. Reprinted with permission from Jones, S.P.;
Gabrielson, N.P.; Wong, C.H.; Chow, H.F.; Pack, D.W.;
Posocco, P.; Fermeglia, M.; Pricl, S.; Smith, D.K. Hydro-
phobically modified dendrons: developing structure-activity re-
lationships for DNA binding and gene transfection. Mol
Pharm., 2011, 8(2), 416–429. Copyright {2012} American
Chemical Society.
Compounds Dm Rc Nagg P m
Chol-G1-SP 3.4 ± 0.1 0.8 21 0.24 5.2
C12Lys-G1-SP 4.0 ± 0.2 1.3 24 0.24 4.3
D2Gly-G1-SP 4.9 ± 0.2 1.5 32 0.32 3.8
C12-G1-SP 4.0 ± 0.1 1.3 16 0.28 2.8
D1Gly-G1-SP 4.0 ± 0.2 0.9 12 0.25 2.1
F i g . 1 4 – Mesoscale modeling of the interaction of DNA with the amphiphilic dendrons D2Gly-G1-SP (left) and C12-G1-SP
(right) as an example. In all pictures, yellow sticks represent dendron head groups. Colored spheres are adopted to represent the vari-
ous hydrophobic regions of the micelles. A light gray field is used to represent water. DNA molecules are depicted as orange sticks.
Reprinted with permission from Jones, S.P.; Gabrielson, N.P.; Wong, C.H.; Chow, H.F.; Pack, D.W.; Posocco, P.; Fermeglia, M.;
Pricl, S.; Smith, D.K. Hydrophobically modified dendrons: developing structure-activity relationships for DNA binding and gene
transfection. Mol Pharm., 2011, 8(2), 416–429. Copyright {2012} American Chemical Society.
Most importantly, the experimentally verified
CE50 values directly correlate with the surface
charge density values m estimated from the
multiscale simulations, indicating that the micelles
characterized by higher values of m (i.e.,
Chol-G1-SP, C12Lys-G1-SP, and D2Gly-G1-SP) are
tighter DNA binders than their counterparts with
lower m values (i.e., C12-G1-SP and D1Gly-G1-SP).
Interestingly, comparing the best DNA binders,
Chol-G1-SP, C12Lys-G1-SP and D2Gly-G1-SP, the
former compound assembles into micelles of much
smaller diameter than the latter two. This is pre-
sumably due to the less sterically demanding nature
of cholesterol leading to more effective packing
within the micellar interior, compared with the
branched hydrophobic units in the latter two
dendrons, which will not be able to pack so effi-
ciently. As such, even though the micelles formed
by Chol-G1-SP contain fewer dendron units and
have less total positive charge than the micelles
formed by C12Lys-G1-SP and D2Gly-G1-Sp, their
smaller size means that they have significantly
higher surface charge density, and as such, they are
therefore much more effective as DNA binders.
According to the classical laws of thermo-
dynamics, the free energy of micellization Gmic –
i.e., the driving force that might eventually lead the
amphiphilic molecules to spontaneously aggregate
in water – can be expressed in the simple form
Gmic = –RTlnKm, where Km is the equilibrium con-
stant between the aggregated and free forms of the
given amphiphile in the aqueous environment. For
conditions near or above the CMC, it can be shown
that the above expression for Gmic can be approxi-
mated to the form Gmic = RTln(CMC). Accord-
ingly, once either Gmic or CMC is known, the
other parameter can be easily estimated through this
simple, fundamental relationship.
From an energetic standpoint, the change in
Gibbs free energy of transfer of a single amphiphilic
molecule from the monomeric state to a micelle of
aggregation number Nagg, that is Gmic, can be
modeled as consisting of a hydrophobic part,
Gmic,h, and an electrostatic part, Gmic,e, so that
Gmic = Gmic,h + Gmic,e. The hydrophobic part
stems primarily from the favorable energy of trans-
fer of the hydrocarbon moieties from the aqueous
phase to the micellar phase, and, secondarily, from
the unfavorable residual interfacial contact of water
with the apolar components within the micelles.
The electrostatic part of Gmic arises from the re-
pulsion between the ionic head groups within the
micellar shell.
Following the theory originally proposed by
Tanford and subsequently modified by other au-
thors, and using the information available from our
multiscale simulations, we were able to calculate
the values of Gmic and the corresponding CMCs
for the five modified dendrons of Figure 12, as
shown in Table 5. As it can be seen from this Table,
Gmic at room temperature has large, negative val-
ues, indicating that micellization is a spontaneous
and highly favorable process for all amphiphilic
dendrons, although Gmic decreases on going from
Chol-G1-SP to D1Gly-G1-SP. Since the head group
architecture is the same in all amphiphiles, the main
differential contribution to Gmic must originate
from the Gmic,h term, which reflects differences in
the size and structure of the hydrophobic compo-
nent.
Typically, micellar aggregates have CMCs of
the order of 10–3–10–5 M, while lower CMCs, even
down to the nanomolar range can be found for
amphiphiles that form either membranes or cylin-
drical aggregates. Recently, however, electron micro-
scopy experiments performed on cholesterol-por-
phyrin micelles revealed that these amphiphiles
could form virtually monodisperse spherical aggre-
gates with a diameter of approximately 7 nm and a
CMC value of 11 nM. Amphiphiles showing low
CMCs tend to have relatively large hydrophobic
segments, and this normally results in an assembly
shape with a lower curvature. However, our series
of modified dendrons combine a large hydrophobic
portion with a very large head group, resulting in a
roughly conical amphiphile. The size of the hydro-
phobic segment is responsible for the low CMCs,
while the large size of the head group results in the
spherical geometry of the assembly.
It is of particular interest to note that the pre-
dicted CMC values for C12-G1-SP and D1Gly-G1-SP
lie above the concentrations of the DNA binding as-
says (i.e. low m concentrations) – as such, it is
possible that the relatively poor DNA binding abil-
ity of these compounds reflects the fact that they
D. MARSON et al., Genes within Bottles. Synergism Between Simulation …, Chem. Biochem. Eng. Q. 26 (4) 447–465 (2012) 463
T a b l e 5 – Predicted free energy of micellization Gmic
(kJ/mol) and critical micelle concentration CMC (M) for the
different modified dendrons of Figure 12. Reprinted with per-
mission from Jones, S.P.; Gabrielson, N.P.; Wong, C.H.; Chow,
H.F.; Pack, D.W.; Posocco, P.; Fermeglia, M.; Pricl, S.; Smith,
D.K. Hydrophobically modified dendrons: developing struc-
ture-activity relationships for DNA binding and gene
transfection. Mol Pharm., 2011, 8(2), 416–429. Copyright







are not aggregated under the experimental condi-
tions as a consequence of their relatively small hy-
drophobic segments. Although a word of caution is
due about the fact that the calculated values of
Gmic and CMC are obtained using validated but
simplified theoretical approaches, the trends exhib-
ited by these parameters are in line with the experi-
mental data. Indeed, we were able to carry out full
experimental aggregation studies on a closely re-
lated set of hydrophobically modified dendrons,
and for these systems, the in silico predictions of
micelle diameters, charge densities and CMC val-
ues were closely mirrored by the experimental re-
sults, both in terms of trends and absolute values,
thus strengthening not only the reliability of the en-
tire computational procedure applied but, perhaps
more importantly, validating its predictive capacity.
In concluding, Figure 15 graphically recaps the
major finding of the study summarized and dis-
cussed above in terms of a graphical perspective of
the qualitative relationship between the main prop-
erties of the self-assembled dendron systems inves-
tigated and their performance as gene delivery
nanovectors.
Conclusions
The extensive series of examples illustrated
and discussed above – taken from our own experi-
ence in the field – emphasizes the role and potenti-
ality of multiscale molecular modeling in the pre-
and post-development of nanodevices for gene de-
livery. Accurate and reliable molecular modeling
can be performed more easily than experiments. In
silico evaluation can take into account the molecu-
lar specificity of the problem and dramatically re-
duce the time and cost required to formulate a new
device and therapeutic intervention, and eventually
translate it into the clinical setting. In nano-
medicine, the need for accurate multiscale molecu-
lar modeling is even more pressing. Despite its
rapid growth and extraordinary potential, the field
is still in its infancy, is highly interdisciplinary, and
aims at solving problems of extraordinary and un-
precedented complexity. With such a scenario,
multiscale molecular modeling could afford a sub-
stantial contribution in dictating the success of
nanomedicine and make the difference between
several years of unfruitful research and the develop-
ment of new, revolutionary therapeutic strategies
readily available to the public.
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